| Year |
Citation |
Score |
| 2023 |
Iv M, Naya L, Sanan S, Van Buskirk SL, Nagpal S, Thomas RP, Recht LD, Patel CB. Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma. The Neuroradiology Journal. 19714009231207083. PMID 37931176 DOI: 10.1177/19714009231207083 |
0.477 |
|
| 2021 |
Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, ... ... Recht LD, et al. A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475101 DOI: 10.1158/1078-0432.CCR-21-0544 |
0.437 |
|
| 2021 |
Beinat C, Patel C, Haywood T, Murty S, Naya L, Hayden-Gephart M, Khalighi M, Massoud T, Iagaru A, Davidzon G, Thomas R, Nagpal S, Recht L, Gambhir S. BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA Neuro-Oncology Advances. 3: i3-i4. DOI: 10.1093/noajnl/vdab024.012 |
0.467 |
|
| 2020 |
Sun J, Patel CB, Jang T, Merchant M, Chen C, Kazerounian S, Diers AR, Kiebish MA, Vishnudas VK, Gesta S, Sarangarajan R, Narain NR, Nagpal S, Recht L. High levels of ubidecarenone (oxidized CoQ) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells. Scientific Reports. 10: 13899. PMID 32807842 DOI: 10.1038/S41598-020-70969-0 |
0.534 |
|
| 2020 |
Jin MC, Liu EK, Shi S, Gibbs IC, Thomas R, Recht L, Soltys SG, Pollom EL, Chang SD, Hayden Gephart M, Nagpal S, Li G. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma. Frontiers in Oncology. 10: 337. PMID 32219069 DOI: 10.3389/Fonc.2020.00337 |
0.341 |
|
| 2019 |
Datta K, Lauritzen MH, Merchant M, Jang T, Liu SC, Hurd R, Recht L, Spielman DM. Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model. Plos One. 14: e0225313. PMID 31830049 DOI: 10.1371/Journal.Pone.0225313 |
0.317 |
|
| 2019 |
Brown JM, Thomas R, Nagpal S, Recht L. Macrophage exclusion after radiation therapy (MERT): A new and effective way to increase the therapeutic ratio of radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 144: 159-164. PMID 31812931 DOI: 10.1016/J.Radonc.2019.11.020 |
0.38 |
|
| 2019 |
Zheng L, Zhang Y, Hao S, Chen L, Sun Z, Yan C, Whitin JC, Jang T, Merchant M, McElhinney DB, Sylvester KG, Cohen HJ, Recht L, Yao X, Ling XB. A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage. Plos One. 14: e0223558. PMID 31600288 DOI: 10.1371/Journal.Pone.0223558 |
0.391 |
|
| 2019 |
Thomas RP, Nagpal S, Iv M, Soltys SG, Bertrand S, Pelpola JS, Ball RL, Yang J, Sundaram V, Lavezo JL, Born DE, Vogel H, Brown JM, Recht L. Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31537527 DOI: 10.1158/1078-0432.Ccr-19-1421 |
0.368 |
|
| 2019 |
Iv M, Liu X, Lavezo J, Gentles AJ, Ghanem R, Lummus S, Born DE, Soltys SG, Nagpal S, Thomas R, Recht L, Fischbein N. Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making. Ajnr. American Journal of Neuroradiology. PMID 31515215 DOI: 10.3174/Ajnr.A6211 |
0.356 |
|
| 2019 |
Patel C, Beinat C, Haywood T, Murty S, Xie Y, Recht L, Nagpal S, Thomas R, Khalighi M, Gandhi H, Holley D, Gambhir S. NIMG-36. EVALUATION OF [18F]DASA-23 FOR NON-INVASIVE MEASUREMENT OF ABERRANTLY EXPRESSED PYRUVATE KINASE M2 IN GLIOMA: FIRST-IN-HUMAN STUDY Neuro-Oncology. 21: vi169-vi169. DOI: 10.1093/Neuonc/Noz175.706 |
0.317 |
|
| 2018 |
Hyman DM, Rizvi NA, Natale RB, Armstrong DK, Birrer MJ, Recht L, Dotan E, Makker V, Kaley TJ, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar MM. Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined With Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29559563 DOI: 10.1158/1078-0432.Ccr-17-1775 |
0.352 |
|
| 2018 |
Dadali T, Kulkarni S, Ng R, Awate P, Mogre S, Diers AR, Jang T, Merchant M, Sun J, Gesta S, Thapa K, Nagpal S, Recht L, Narain NR, Sarangarajan R. Abstract 873: BPM 31510, a clinical stage metabolic modulator, demonstrates therapeutic efficacy in glioblastoma models of temozolomide chemo-sensitive and resistance by targeting mitochondrial function Cancer Research. 78: 873-873. DOI: 10.1158/1538-7445.Am2018-873 |
0.326 |
|
| 2017 |
Brown JM, Recht L, Strober S. The Promise of Targeting Macrophages in Cancer Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28341752 DOI: 10.1158/1078-0432.Ccr-16-3122 |
0.372 |
|
| 2017 |
Gesta S, Nagpal S, Dadali T, Merchant M, Jan T, Diers AR, Kiebish M, Jiminez J, Vishnudas VK, Narain NR, Sarangarajan R, Recht L. Abstract 4067: BPM31510, a clinical stage metabolic modulator demonstrates therapeutic efficacy in anin vivoC6 rat glioma model and synergizes with temozolomide Cancer Research. 77: 4067-4067. DOI: 10.1158/1538-7445.Am2017-4067 |
0.367 |
|
| 2017 |
Recht L, Nagpal S, Jang T, Merchant M, Choi I, Hoch U, Charych D. Abstract 1598: Single agent NKTR-214, a biased IL2 pathway agonist, increases immune cell infiltrates in brain tumors and prolongs survival in rodent (rattus) glioblastoma (GBM) Cancer Research. 77: 1598-1598. DOI: 10.1158/1538-7445.Am2017-1598 |
0.397 |
|
| 2016 |
Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP. Response of metastatic glioma to vemurafenib. Neuro-Oncology Practice. 3: 268-271. PMID 31386052 DOI: 10.1093/Nop/Npv054 |
0.347 |
|
| 2016 |
Deng L, Stafford JH, Liu SC, Chernikova SB, Merchant M, Recht L, Martin Brown J. SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI. Neoplasia (New York, N.Y.). 19: 1-7. PMID 27940247 DOI: 10.1016/J.Neo.2016.11.010 |
0.309 |
|
| 2016 |
Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, Brandes AA, Pineda E, Mikkelsen T, Chinot OL, Balana C, Macdonald DR, Westphal M, Hopkins K, Weller M, Bais C, Sandmann T, et al. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O(6)-Methylguanine-DNA Methyltransferase Biomarker Analyses. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2015647685. PMID 27918718 DOI: 10.1200/Jco.2015.64.7685 |
0.349 |
|
| 2015 |
Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, ... ... Recht L, et al. Central Nervous System Cancers, Version 1.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1191-202. PMID 26483059 DOI: 10.6004/Jnccn.2015.0148 |
0.362 |
|
| 2015 |
Tan Z, Liu R, Zheng L, Hao S, Fu C, Li Z, Deng X, Jang T, Merchant M, Whitin JC, Guo M, Cohen HJ, Recht L, Ling XB. Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis. Methods (San Diego, Calif.). 83: 36-43. PMID 25982164 DOI: 10.1016/J.Ymeth.2015.05.004 |
0.334 |
|
| 2015 |
Bui TT, Nitta RT, Kahn SA, Razavi SM, Agarwal M, Aujla P, Gholamin S, Recht L, Li G. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. Bmc Cancer. 15: 225. PMID 25884624 DOI: 10.1186/S12885-015-1232-Y |
0.344 |
|
| 2015 |
Thomas RP, Gibbs IC, Xu LW, Recht L. Treatment options for optic pathway gliomas. Current Treatment Options in Neurology. 17: 333. PMID 25619537 DOI: 10.1007/S11940-014-0333-2 |
0.376 |
|
| 2015 |
Xu LW, Recht L. Nimg-74Enhancing Lesions Outside The Irradiated Field In Anaplastic Oligodendroglioma: Tumor Or Not? Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.74 |
0.389 |
|
| 2014 |
Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, ... ... Recht L, et al. Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1517-23. PMID 25361798 DOI: 10.6004/Jnccn.2014.0151 |
0.37 |
|
| 2014 |
Ajlan A, Recht L. Supratentorial low-grade diffuse astrocytoma: medical management. Seminars in Oncology. 41: 446-57. PMID 25173138 DOI: 10.1053/J.Seminoncol.2014.06.013 |
0.341 |
|
| 2014 |
Chamberlain MC, Grimm S, Phuphanich S, Recht L, Zhu JZ, Kim L, Rosenfeld S, Fadul CE. A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC). Journal of Neuro-Oncology. 118: 335-43. PMID 24740196 DOI: 10.1007/S11060-014-1437-Y |
0.331 |
|
| 2014 |
Liu SC, Alomran R, Chernikova SB, Lartey F, Stafford J, Jang T, Merchant M, Zboralski D, Zöllner S, Kruschinski A, Klussmann S, Recht L, Brown JM. Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats. Neuro-Oncology. 16: 21-8. PMID 24335554 DOI: 10.1093/Neuonc/Not149 |
0.381 |
|
| 2014 |
Thomas R, Ajlan A, Ziskin J, Soltys S, Reddy S, Recht L, Nagpal S. Nt-34Complete Response To Vemurafinib In A Patient With Metastatic Anaplastic Xanthroastrocytoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou265.32 |
0.331 |
|
| 2014 |
Razis E, Vlahovic G, Recht L, Wheeler H, Reardon D, Fisher PG, Owen S, Nicholas K, Paradise E, Yellin M, Davis T, Weller M, Stupp R, Hottinger AF. It-28Vaccination Against Epidermal Growth Factor Receptor Variant Iii In Glioblastoma: The Rindopepimut Compassionate Use Experience Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou258.26 |
0.363 |
|
| 2014 |
Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, Brandes AA, Pineda E, Mikkelsen T, Chinot O, Balana C, Macdonald D, Westphal M, Hopkins K, Weller M, Bruey J, Liu B, et al. ET-12 * PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA Neuro-Oncology. 16: v81-v81. DOI: 10.1093/Neuonc/Nou255.12 |
0.353 |
|
| 2014 |
Ajlan A, Thomas P, Thomas R, Nagpal S, Recht L. Ai-01Are We Using Too Much Bevacizumab In Our Gbm Patients? Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou238.1 |
0.301 |
|
| 2013 |
Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, ... ... Recht L, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 1114-51. PMID 24029126 DOI: 10.6004/Jnccn.2013.0132 |
0.421 |
|
| 2013 |
Lin CY, Siow TY, Lin MH, Hsu YH, Tung YY, Jang T, Recht L, Chang C. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA. Angiogenesis. 16: 785-93. PMID 23736837 DOI: 10.1007/S10456-013-9355-8 |
0.37 |
|
| 2013 |
Recht L, Mechtler LL, Wong ET, O'Connor PC, Rodda BE. Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1182-7. PMID 23382470 DOI: 10.1200/Jco.2012.43.9455 |
0.358 |
|
| 2013 |
Yamaguchi Y, Shao Z, Sharif S, Du XY, Myles T, Merchant M, Harsh G, Glantz M, Recht L, Morser J, Leung LL. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. The Journal of Biological Chemistry. 288: 3097-111. PMID 23204518 DOI: 10.1074/Jbc.M112.362954 |
0.318 |
|
| 2012 |
Whitin JC, Jang T, Merchant M, Yu TT, Lau K, Recht B, Cohen HJ, Recht L. Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model. Plos One. 7: e49724. PMID 23185417 DOI: 10.1371/Journal.Pone.0049724 |
0.349 |
|
| 2011 |
Nagpal S, Harsh G, Recht L. Bevacizumab improves quality of life in patients with recurrent glioblastoma. Chemotherapy Research and Practice. 2011: 602812. PMID 22312554 DOI: 10.1155/2011/602812 |
0.337 |
|
| 2011 |
Nagpal S, Recht L. Treatment and prophylaxis of hematologic malignancy in the central nervous system. Current Treatment Options in Neurology. 13: 400-12. PMID 21484261 DOI: 10.1007/S11940-011-0128-7 |
0.362 |
|
| 2011 |
Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, ... ... Recht L, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 352-400. PMID 21464144 DOI: 10.6004/Jnccn.2011.0036 |
0.318 |
|
| 2011 |
Barretto RP, Ko TH, Jung JC, Wang TJ, Capps G, Waters AC, Ziv Y, Attardo A, Recht L, Schnitzer MJ. Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy. Nature Medicine. 17: 223-8. PMID 21240263 DOI: 10.1038/Nm.2292 |
0.302 |
|
| 2011 |
Jang T, Calaoagan JM, Kwon E, Samuelsson S, Recht L, Laderoute KR. 5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. International Journal of Cancer. Journal International Du Cancer. 128: 2230-9. PMID 20635388 DOI: 10.1002/Ijc.25558 |
0.364 |
|
| 2010 |
Nagpal S, Glantz MJ, Recht L. Treatment and prevention of secondary CNS lymphoma. Seminars in Neurology. 30: 263-72. PMID 20577933 DOI: 10.1055/S-0030-1255222 |
0.327 |
|
| 2009 |
Glantz M, Kesari S, Recht L, Fleischhack G, Van Horn A. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Seminars in Oncology. 36: S17-24. PMID 19660679 DOI: 10.1053/J.Seminoncol.2009.05.003 |
0.423 |
|
| 2009 |
Glantz MJ, Chamberlain MC, Liu Q, Hsieh CC, Edwards KR, Van Horn A, Recht L. Gender disparity in the rate of partner abandonment in patients with serious medical illness. Cancer. 115: 5237-42. PMID 19645027 DOI: 10.1002/Cncr.24577 |
0.374 |
|
| 2009 |
Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, et al. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. International Journal of Radiation Oncology, Biology, Physics. 73: 1069-76. PMID 18977094 DOI: 10.1016/J.Ijrobp.2008.05.068 |
0.342 |
|
| 2006 |
Kuo T, Recht L. Optimizing therapy for patients with brain metastases. Seminars in Oncology. 33: 299-306. PMID 16769418 DOI: 10.1053/J.Seminoncol.2006.03.005 |
0.384 |
|
| 2004 |
Colocci N, Glantz M, Recht L. Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature. Seminars in Neurology. 24: 395-404. PMID 15637651 DOI: 10.1055/S-2004-861534 |
0.32 |
|
| 1990 |
Recht L, Fram RJ, Strauss G, Fitzgerald TJ, Liepman M, Lew R, Kadish S, Sherman D, Wilson J, Greenberger J. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial. American Journal of Clinical Oncology. 13: 125-31. PMID 2156417 DOI: 10.1097/00000421-199004000-00008 |
0.314 |
|
| Show low-probability matches. |